Table 2 Comparison of hypertension grading/classification systems

From: Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK

Guidance

Blood pressure mmHg

Acute organ damage

≥120/80

≥130/85

≥140/90

>150/100

≥160/100

≥180/110

CTCAE v.376

–

• Grade 1: asymptomatic transient increase

• Grade 2: symptomatic recurrent/persistent increase requiring monotherapy

• Grade 3: requiring >1 drug or more intensive therapy

Grade 4

CTCAE v.542

Grade 1

Grade 2

Grade 3

Grade 4

NICE guidance68

Normal

Stage 1

Stage 2

Severe

Hypertensive emergency

ESH/ESC guidance51

Normal

High normal

Grade 1

Grade 2

Grade 3

Hypertensive emergency

  1. CTCAE Common Terminology Criteria for Adverse Events, ESC European Society of Cardiology, ESH European Society of Hypertension, NICE National Institute for Health and Care Excellence
Back to article page